Stephen Wolverton

  • 303 Citations
  • 10 h-Index
1985 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Review article
2016

Practice Gaps: Drug Reactions

Wolverton, S., Jul 1 2016, In : Dermatologic Clinics. 34, 3, p. 311-318 8 p.

Research output: Contribution to journalReview article

1 Scopus citations
2013

Important controversies associated with isotretinoin therapy for acne

Wolverton, S. E. & Harper, J. C., Apr 1 2013, In : American Journal of Clinical Dermatology. 14, 2, p. 71-76 6 p.

Research output: Contribution to journalReview article

25 Scopus citations
2011

Immunosuppression and sebaceous tumors: A confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy

Landis, M. N., Davis, C. L., Bellus, G. A. & Wolverton, S. E., Nov 2011, In : Journal of the American Academy of Dermatology. 65, 5, p. 1054-1058.e1

Research output: Contribution to journalReview article

24 Scopus citations
2009

Can short courses of systemic corticosteroids truly cause osteonecrosis?

Wolverton, S. E., Sep 1 2009, In : Dermatologic Therapy. 22, 5, p. 458-464 7 p.

Research output: Contribution to journalReview article

4 Scopus citations
2007

Suggested Guidelines for Patient Monitoring: Hepatic and Hematologic Toxicity Attributable to Systemic Dermatologic Drugs

Wolverton, S. E. & Remlinger, K., Apr 1 2007, In : Dermatologic Clinics. 25, 2, p. 195-205 11 p.

Research output: Contribution to journalReview article

21 Scopus citations

The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.

Allen, K. J. & Wolverton, S. E., Sep 2007, In : Journal of drugs in dermatology : JDD. 6, 9, p. 883-889 7 p.

Research output: Contribution to journalReview article

21 Scopus citations
1997

Update on cutaneous drug reactions.

Wolverton, S. E., 1997, In : Advances in dermatology. 13, p. 65-84 20 p.

Research output: Contribution to journalReview article

11 Scopus citations